SynthesisMedicine2017

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumor after failure with imatinib and sunitinib treatment: A meta-analysis.

Zhenan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.